PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Children\'s University Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.\', \'Institute of Transfusion Medicine, Eberhard Karls University Tuebingen, Tuebingen, Germany.\', \'Children\'s Hospital, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany.\', \'Institute of Pathology, Eberhard Karls University Tuebingen, Tuebingen, Germany.\', \'Department of Haematology/Oncology, Eberhard Karls University Tuebingen, Tuebingen, Germany.\', \'University Hospital for Intensive Care and Anaesthesiology, Eberhard Karls University Tuebingen, Tuebingen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jpids/piaa117
?:hasPublicationType
?:journal
  • Journal of the Pediatric Infectious Diseases Society
is ?:pmid of
?:pmid
?:pmid
  • 32951037
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.332
?:rankingScore_hIndex
  • 16
is ?:relation_isRelatedTo_publication of
?:title
  • Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all